DBVTDBV Technologies S.A.

$9.51-33% 1Y
Latest close: a new 52-week lowOct 8, 2026what changed →

Price

-33%1Y

End-of-day closes, not the intraday tick.

The checks lean against it

Quality shaky, a flag to check, growth steady, the market against it.

RyuScore 9 of 100: see how it is built
P/En/a
Market value$562.9M
1 year-33%
5 years-3.0%

Charts

As reported to the SEC, without any scoring.

DBV Technologies S.A. (DBVT) reported revenue of $700K in Q2 2026 (quarter ended Jun 30, 2026), down 53% from the same quarter a year earlier. That came with net loss of $50M. For the full year FY2025, revenue was $5.6M (+36% year on year) and net income −$147M. The next results filing is expected around Oct 28, 2026, the same week as a year ago.

What the company said

The company's own words from its current reports to the SEC, newest first

  1. Sep 30, 2026DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN ® Peanut Patch in Children Aged 4-7 Years.Other event · press release
  2. Jul 16, 2026Châtillon, France, July 16, 2026.Earnings release · press release
  3. Jun 29, 2026Châtillon, France, June 29, 2026.Other event · press release

Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.

Why these answers

Each answer with the checks it was read from. Open one for the numbers.

5/19 checks · as of Oct 8, 2026

Conflicts between checks are named, never averaged, and thin data says so.